Credit Agricole S A Has $1.64 Million Stock Holdings in Select Medical Holdings Corporation $SEM

Key Points

• Credit Agricole S A significantly increased its stake in Select Medical Holdings Corporation by 98.8%, now owning 98,044 shares valued at approximately $1.64 million.
• Select Medical's shares are currently trading at $13.40, showing a 3.2% increase, and the company reported quarterly earnings of $0.32 per share, surpassing estimates.
• The company has announced a $1.00 billion stock buyback plan and will pay a quarterly dividend of $0.0625, reflecting a 1.9% yield for investors.

Credit Agricole S A boosted its holdings in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 98.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 98,044 shares of the health services provider's stock after acquiring an additional 48,734 shares during the period. Credit Agricole S A owned 0.08% of Select Medical worth $1,637,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of SEM. Barclays PLC grew its holdings in Select Medical by 29.6% during the 4th quarter. Barclays PLC now owns 249,209 shares of the health services provider's stock worth $4,698,000 after acquiring an additional 56,852 shares during the period. First Trust Advisors LP grew its holdings in Select Medical by 106.0% during the 4th quarter. First Trust Advisors LP now owns 121,647 shares of the health services provider's stock worth $2,293,000 after acquiring an additional 62,592 shares during the period. Dimensional Fund Advisors LP lifted its position in Select Medical by 1.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,431,469 shares of the health services provider's stock valued at $83,533,000 after acquiring an additional 62,585 shares in the last quarter. MetLife Investment Management LLC lifted its position in Select Medical by 6.7% in the 4th quarter. MetLife Investment Management LLC now owns 65,812 shares of the health services provider's stock valued at $1,241,000 after acquiring an additional 4,105 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in Select Medical by 165.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 12,551 shares of the health services provider's stock valued at $237,000 after acquiring an additional 7,828 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company's stock.

Select Medical Stock Performance

SEM traded down $0.10 on Friday, reaching $12.94. The company had a trading volume of 265,395 shares, compared to its average volume of 1,129,994. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.15 and a current ratio of 1.15. The stock has a market cap of $1.60 billion, a P/E ratio of 12.19, a P/E/G ratio of 0.53 and a beta of 1.25. Select Medical Holdings Corporation has a fifty-two week low of $11.65 and a fifty-two week high of $40.98. The company's fifty day moving average is $13.89 and its 200 day moving average is $15.56.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 earnings per share for the quarter, topping analysts' consensus estimates of $0.28 by $0.04. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The company had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter in the prior year, the firm posted $0.60 EPS. The firm's quarterly revenue was up 4.5% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. As a group, analysts predict that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical announced that its Board of Directors has authorized a share buyback program on Thursday, May 1st that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the health services provider to reacquire up to 42.6% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's management believes its stock is undervalued.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th were issued a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Wednesday, August 13th. Select Medical's dividend payout ratio is 23.58%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on SEM shares. UBS Group reiterated a "neutral" rating and issued a $14.00 price target (down from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Royal Bank Of Canada decreased their price target on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 7th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, Select Medical presently has a consensus rating of "Moderate Buy" and a consensus price target of $20.25.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.